Delivery Order SPE2DB20D1100-SPE2DB24FZ86C
Award Date 1/23/24
Potential Completion Date 2/13/24
Potential Value $1.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The contract is a delivery order valued at $1,873.74 for the supply of ZOLADEX 3.6 MG IMPLANT SYRNS, with a completion date of March 4, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ZOLADEX 3.6 MG IMPLANT SYRNS. The contract, valued at $1,873.74, is a Firm Fixed Price Delivery Order with a completion date of September 16, 2024. Amerisourcebergen, through its Corporate Office division, is the prime contractor for this award, which does not have a set-aside designation. The contract is part of...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,336.98 firm fixed-price delivery order is for the supply of ZOLADEX 10.8 MG IMPLANT SYRNS medical products. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $1,292.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZOLADEX 3.6 MG IMPLANT SYRNS, a specialty medication. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical valued at $1,249.20. The award is for the delivery of ZOLADEX 3.6 MG IMPLANT SYRNS, a specialized pharmaceutical product, with a completion date of March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $1,249.20, is a Firm Fixed Price Delivery Order for the supply of ZOLADEX 3.6 MG IMPLANT SYRNS, a cancer medication. The contract has an ultimate completion date of October 2, 2024. Amerisourcebergen, as one of the largest pharmaceutical distributors in the United States, leverages its extensive...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,971.64, is for the delivery of ZOLADEX 3.6 MG IMPLANT SYRNS, a pharmaceutical product. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,191,600 units of ZOLADEX 10.8 MG IMPLANT SYRNS. The $16,919.60 award has a completion date of January 18, 2024 and was made on December 26, 2023. Amerisourcebergen Drug Corp, as a prime contractor, has a history of supplying pharmaceuticals, medical supplies, and distribution services to support DLA Troop Support Medical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,938.54, is a Firm Fixed Price Delivery Order for the supply of ZOLADEX 3.6 MG IMPLANT SYRNS, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $1,873.74, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product ZOLADEX 3.6 MG IMPLANT SYRNS, with a completion date of May 10, 2024. Amerisourcebergen, a large pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...